Recurrent systemic pneumococcal disease in children

Pediatric Infectious Disease Journal

Volumn 26, Issue 6, 2007, Pages 480-484

  Mason Jr , Edward O ^a,i   Wald, Ellen R ^b   Tan, Tina Q ^c   Schutze, Gordon E ^d   Bradley, John S ^e   Barson, William J ^f   Givner, Laurence B ^g   Hoffman, Jill ^h   Kaplan, Sheldon L ^a  

^a TEXAS CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^g WAKE FOREST SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

ⁱ BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Invasive pneumococcal disease; Recurrent infection; Streptococcus pneumoniae

Indexed keywords

CEFTRIAXONE; PENICILLIN G;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CHILD; CHILDHOOD DISEASE; CONTROLLED STUDY; DEMOGRAPHY; DILUTION; DISEASE DURATION; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULSED FIELD GEL ELECTROPHORESIS; RECURRENT INFECTION; RETROSPECTIVE STUDY; SEROTYPE; STATISTICAL ANALYSIS; STREPTOCOCCUS INFECTION; SYSTEMIC DISEASE;

ANTI-BACTERIAL AGENTS; BACTEREMIA; CEFTRIAXONE; CELLULITIS; CHILD; CHILD, PRESCHOOL; DNA FINGERPRINTING; DNA, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; GENOTYPE; HUMANS; IMMUNOCOMPROMISED HOST; INFANT; MALE; MICROBIAL SENSITIVITY TESTS; PENICILLINS; PNEUMOCOCCAL INFECTIONS; PNEUMONIA, PNEUMOCOCCAL; RECURRENCE; SEROTYPING; STREPTOCOCCUS PNEUMONIAE;

EID: 34249819667     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/INF.0b013e31805ce277     Document Type: Article

References (20)

1. Gransden WR, Eykyn SJ. Recurrent pneumococcal bacteremia [comment]-. Clin Infect Dis. 1992;15:1072-1073.
2. Orlicek SL, Herrod HG, Leggiadro RJ, Luedtke G, English BK. Repeated invasive pneumococcal infections in young children without apparent underlying immunodeficiency. J Pediatr. 1997;130:284-288.
3. Coccia MR, Facklam RR, Saravolatz LD, Manzor O. Recurrent pneumococcal bacteremia: 34 episodes in 15 patients. Clin Infect Dis. 1998;26:982-985.
4. McEllistrem MC, Mendelsohn AB, Pass MA, et al. Recurrent invasive pneumococcal disease in individuals with human immunodeficiency virus infection. J Infect Dis. 2002;185:1364-1368.
5. Lee W, Austrian R, Weiser JN. Recurrent pneumococcal bacteremia in normal children. Pediatr Infect Dis J. 1994;13:231-233.
6. Kaplan SL, Mason EO Jr, Barson WJ, et al. Three-year multicenter surveillance of systemic pneumococcal infections in children. Pediatrics. 1998;102:538-545.
7. Kaplan SL, Mason EO Jr, Wald E, et al. Six year multicenter surveillance of invasive pneumococcal infections in children. Pediatr Infect Dis J. 2002;21:141-147.
8. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. CLSI Document M100-S16. Sixteenth Informational Supplement. Pennsylvania: Clinical and Laboratory Standards Institute; 2006.
9. Murray BE, Singh KV, Heath JD, Sharma BR, Weinstock GM. Comparison of genomic DNAs of different enterococcal isolates using restriction endonucleases with infrequent recognition sites. J Clin Microbiol. 1990;28:2059-2063.
10. Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol. 1995;33:2233-2239.
11. Kuhls TL, Viering TP, Leach CT, Steele MI, Haglund LA, Fine DP. Relapsing pneumococcal bacteremia in immunocompromised patients. Clin Infect Dis. 1992;14:1050-1054.
12. Gransden WR, Eykyn SJ. Relapsing pneumococcal bacteremia in immunocompromised patients. Clin Infect Dis. 1992;15:558-559.
13. Reinert RR, Büssing A, Kierdorf H, Kühnemund O, Kaufhold A. Recurrent systemic pneumococcal infection in an immunocompromised patient. Eur J Clin Microbiol Infect Dis. 1994;13:304-307.
14. King MD, Whitney CG, Parekh F, Farley MM. Recurrent invasive pneumococcal disease: a population-based assessment. Clin Infect Dis. 2003;37:1029-1036.
15. American Academy of Pediatrics Committee on Infectious Diseases. Recommendations for the prevention of pneumococcal infections, including the use of pneumococcal conjugate vaccine (Prevnar), pneumococcal polysaccharide vaccine, and antibiotic prophylaxis. Pediatrics. 2000;106:362-366.
16. American Academy of Pediatrics. Pneumococcal infections. In: Pickering LK, Baker CJ, Long SS, McMillan JA, eds. Red book: 2006 Report of the Committee on Infectious Diseases. 27th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2006.
17. Avery OT, MacLeod CM, McCarty M. Studies on the chemical nature of the substance inducing transformation of pneumococcal types: induction of transformation by a desxoyribonucleic acid fraction isolated from a pneumococcus type III. Mol Med. 1955;1:344-365.
18. McEllistrem MC, Adams J, Mason EO, Wald ER. Epidemiology of acute otitis media caused by Streptococcus pneumoniae before and after licensure of the 7-valent pneumococcal protein conjugate vaccine. J Infect Dis. 2003;188:1679-1684.
19. Nesin M, Ramirez M, Tomasz A. Capsular transformation of a multidrug-resistant Streptococcus pneumoniae in vivo. J Infect Dis. 1998;177:707-713.
20. Meats E, Brueggemann AB, Enright MC, et al. Stability of serotypes during nasopharyngeal carriage of Streptococcus pneumoniae. J Clin Microbiol. 2003;41:386-392.